• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

贝切特病中的调节性 T 细胞:与疾病活动度是否存在相关性?调节性 T 细胞类型是否重要?

Regulatory T cells in Behçet's disease: is there a correlation with disease activity? Does regulatory T cell type matter?

机构信息

Department of Hematology, School of Medicine, Eskişehir Osmangazi University, Eskisehir, 26480, Turkey,

出版信息

Rheumatol Int. 2013 Dec;33(12):3049-54. doi: 10.1007/s00296-013-2835-8. Epub 2013 Aug 3.

DOI:10.1007/s00296-013-2835-8
PMID:23912800
Abstract

The aim of this study was to investigate the percentage of regulatory T cells and the correlation with clinical activity in Behçet's disease. Forty Behçet's disease (BD) patients, 18 males and 22 females, were included in the study. The patients were diagnosed according to the published BD criteria. Twenty age- and sex-matched volunteer healthy donors were also included. At the time of sampling, clinical activity was assessed for activity signs and symptoms according to the BD Current Activity Form. We considered active those patients with a clinical activity index equal to and/or above 2. Eleven patients had active disease and the remaining were considered as clinically inactive. We have studied the percentages of CD4+CD25+FOXP3+, CD4+CD25+ and CD4+FOXP3+regulatory T cells by flow cytometry and investigated the correlation with disease activity. Percentage of CD4+CD25+FOXP3+Treg in active patients was lower than clinically inactive patients and healthy controls. Percentage of CD4+CD25+Treg was not different between active and inactive patients and healthy controls. Percentage of CD4+FOXP3+Treg was lower than healthy controls in clinically active patients but was not different for inactive group and healthy controls. Patients were active when CD4+CD25+FOXP3+Treg was ≤1.19 %, CD4+CD25+Treg was ≤2.68 %, and CD4+FOXP3+Treg was ≤2.60. CD4+CD25+FOXP3+Treg and CD4+FOXP3+Treg were found negatively correlated with disease activity. Peripheral blood regulatory T cells are decreased in clinically active Behçet's disease patients. The advances in our understanding of the interactions between distinct subsets of Treg and clinical activity might help in modulating BD treatment.

摘要

本研究旨在探讨调节性 T 细胞(Treg)的百分比及其与白塞病(BD)临床活动的相关性。共纳入 40 例 BD 患者(男 18 例,女 22 例),根据已发表的 BD 标准进行诊断。同时纳入 20 名年龄和性别匹配的健康志愿者作为对照。在采样时,根据 BD 当前活动表评估了活动体征和症状的临床活动。我们将临床活动指数等于和/或高于 2 的患者视为活动患者。11 例患者患有活动性疾病,其余患者被认为是临床非活动性疾病。我们通过流式细胞术研究了 CD4+CD25+FOXP3+、CD4+CD25+和 CD4+FOXP3+调节性 T 细胞的百分比,并探讨了其与疾病活动的相关性。与临床非活动性患者和健康对照组相比,活动患者的 CD4+CD25+FOXP3+Treg 百分比较低。活性患者和非活性患者与健康对照组之间的 CD4+CD25+Treg 百分比无差异。与健康对照组相比,临床活动患者的 CD4+FOXP3+Treg 百分比较低,但与非活动组和健康对照组无差异。当 CD4+CD25+FOXP3+Treg ≤1.19%、CD4+CD25+Treg ≤2.68%和 CD4+FOXP3+Treg ≤2.60 时,患者处于活动状态。CD4+CD25+FOXP3+Treg 和 CD4+FOXP3+Treg 与疾病活动呈负相关。临床活动期白塞病患者外周血调节性 T 细胞减少。对不同亚群 Treg 与临床活动之间相互作用的深入了解,可能有助于调节 BD 的治疗。

相似文献

1
Regulatory T cells in Behçet's disease: is there a correlation with disease activity? Does regulatory T cell type matter?贝切特病中的调节性 T 细胞:与疾病活动度是否存在相关性?调节性 T 细胞类型是否重要?
Rheumatol Int. 2013 Dec;33(12):3049-54. doi: 10.1007/s00296-013-2835-8. Epub 2013 Aug 3.
2
CD4+CD25+ regulatory T cells in patients with Behçet's disease.白塞病患者的CD4+CD25+调节性T细胞
Clin Exp Rheumatol. 2006 Sep-Oct;24(5 Suppl 42):S71-8.
3
Interleukin-2, interleukin-6 and T regulatory cells in peripheral blood of patients with Behçet's disease and recurrent aphthous ulcerations.白塞病和复发性口腔溃疡患者外周血中白细胞介素 2、白细胞介素 6 和 T 调节细胞。
J Oral Pathol Med. 2012 Jan;41(1):73-9. doi: 10.1111/j.1600-0714.2011.01061.x. Epub 2011 Jul 8.
4
Low expressions of PD-L1 and CTLA-4 by induced CD4CD25 Foxp3 Tregs in patients with SLE and their correlation with the disease activity.SLE 患者诱导的 CD4CD25 Foxp3 Treg 细胞中 PD-L1 和 CTLA-4 的低表达及其与疾病活动的相关性。
Cytokine. 2020 Sep;133:155119. doi: 10.1016/j.cyto.2020.155119. Epub 2020 Jun 11.
5
Induction of regulatory T cells by infliximab in Behcet's disease.英夫利昔单抗诱导白塞病调节性 T 细胞。
Invest Ophthalmol Vis Sci. 2011 Jan 21;52(1):476-84. doi: 10.1167/iovs.10-5916.
6
CD4(+) CD25(+) regulatory T cells ameliorate Behcet's disease-like symptoms in a mouse model.CD4(+) CD25(+) 调节性 T 细胞可改善小鼠模型中的白塞病样症状。
Cytotherapy. 2011 Aug;13(7):835-47. doi: 10.3109/14653249.2011.571245. Epub 2011 Apr 21.
7
Dysfunctional CD4+,CD25+ regulatory T cells in untreated active systemic lupus erythematosus secondary to interferon-alpha-producing antigen-presenting cells.继发于产生干扰素-α的抗原呈递细胞的未经治疗的活动性系统性红斑狼疮中功能失调的CD4 +、CD25 +调节性T细胞。
Arthritis Rheum. 2008 Mar;58(3):801-12. doi: 10.1002/art.23268.
8
Blockade of TGF-β signaling to enhance the antitumor response is accompanied by dysregulation of the functional activity of CD4CD25Foxp3 and CD4CD25Foxp3 T cells.阻断 TGF-β 信号转导增强抗肿瘤反应的同时,也伴随着 CD4CD25Foxp3 和 CD4CD25Foxp3 T 细胞功能活性的失调。
J Transl Med. 2019 Jul 9;17(1):219. doi: 10.1186/s12967-019-1967-3.
9
The relation of CD4CD25+Foxp3+ regulatory T cells concentration with disease activity and damage index in systemic lupus erythematosus.CD4CD25+Foxp3+ 调节性 T 细胞浓度与系统性红斑狼疮疾病活动度和损伤指数的关系。
Lupus. 2022 Apr;31(4):463-471. doi: 10.1177/09612033221083269. Epub 2022 Mar 7.
10
Decreased levels of circulating CD4+CD25+Foxp3+ regulatory T cells in patients with primary antiphospholipid syndrome.原发性抗磷脂综合征患者循环中 CD4+CD25+Foxp3+调节性 T 细胞水平降低。
J Clin Immunol. 2013 May;33(4):876-9. doi: 10.1007/s10875-012-9857-y. Epub 2013 Jan 29.

引用本文的文献

1
Molecular and therapeutic effects of mesenchymal stem cell-derived exosomes on autoimmune diseases.间充质干细胞衍生外泌体对自身免疫性疾病的分子及治疗作用
World J Stem Cells. 2025 Jul 26;17(7):107202. doi: 10.4252/wjsc.v17.i7.107202.
2
Neopterin Levels and Immune Response in Autoimmune Uveitis in an Experiment.实验性自身免疫性葡萄膜炎中蝶呤水平与免疫反应
Korean J Ophthalmol. 2025 Jun;39(3):258-268. doi: 10.3341/kjo.2024.0118. Epub 2025 May 28.
3
Altered polyunsaturated fatty acids and oxylipins profile in Behçet's disease.白塞病中多不饱和脂肪酸和氧化脂质谱的改变。

本文引用的文献

1
New insights into the pathogenesis of Behçet's disease.对贝赫切特病发病机制的新认识。
Autoimmun Rev. 2012 Aug;11(10):687-98. doi: 10.1016/j.autrev.2011.11.026. Epub 2011 Dec 11.
2
[The changes of Th lymphocyte subsets in patients with Behcet disease].[白塞病患者Th淋巴细胞亚群的变化]
Zhonghua Yan Ke Za Zhi. 2011 May;47(5):393-7.
3
Interleukin-2, interleukin-6 and T regulatory cells in peripheral blood of patients with Behçet's disease and recurrent aphthous ulcerations.白塞病和复发性口腔溃疡患者外周血中白细胞介素 2、白细胞介素 6 和 T 调节细胞。
Korean J Intern Med. 2025 May;40(3):502-511. doi: 10.3904/kjim.2024.033. Epub 2025 Feb 21.
4
Finding the Needle in the Haystack: Serological and Urinary Biomarkers in Behçet's Disease: A Systematic Review.从海量数据中寻找关键线索:白塞病的血清学和尿液生物标志物:系统评价。
Int J Mol Sci. 2023 Feb 3;24(3):3041. doi: 10.3390/ijms24033041.
5
Regulatory T Cells in Autoimmune Vasculitis.自身免疫性血管炎中的调节性 T 细胞。
Front Immunol. 2022 Feb 28;13:844300. doi: 10.3389/fimmu.2022.844300. eCollection 2022.
6
Immunopathophysiology and clinical impact of uveitis in inflammatory rheumatic diseases: An update.炎症性风湿病中葡萄膜炎的免疫病理生理学和临床影响:最新进展。
Eur J Clin Invest. 2021 Aug;51(8):e13572. doi: 10.1111/eci.13572. Epub 2021 May 5.
7
[Efficacy and safety of metformin for Behcet's disease and its effect on Treg/Th17 balance: a single-blinded, before-after study].二甲双胍治疗白塞病的疗效与安全性及其对Treg/Th17平衡的影响:一项单盲前后对照研究
Nan Fang Yi Ke Da Xue Xue Bao. 2019 Feb 28;39(2):127-133. doi: 10.12122/j.issn.1673-4254.2019.02.01.
8
Knitting the Threads of Silk through Time: Behçet's Disease-Past, Present, and Future.穿越时光编织丝线:白塞病的过去、现在与未来
Int J Rheumatol. 2017;2017:2160610. doi: 10.1155/2017/2160610. Epub 2017 Sep 10.
J Oral Pathol Med. 2012 Jan;41(1):73-9. doi: 10.1111/j.1600-0714.2011.01061.x. Epub 2011 Jul 8.
4
Critical role of IL-21 in modulating TH17 and regulatory T cells in Behçet disease.IL-21 在调控 Behcet 病中 TH17 和调节性 T 细胞中的关键作用。
J Allergy Clin Immunol. 2011 Sep;128(3):655-64. doi: 10.1016/j.jaci.2011.05.029. Epub 2011 Jul 2.
5
Moving to tolerance: clinical application of T regulatory cells.向耐受转化:调节性 T 细胞的临床应用。
Semin Immunol. 2011 Aug;23(4):304-13. doi: 10.1016/j.smim.2011.04.001. Epub 2011 May 28.
6
CD4(+) CD25(+) regulatory T cells ameliorate Behcet's disease-like symptoms in a mouse model.CD4(+) CD25(+) 调节性 T 细胞可改善小鼠模型中的白塞病样症状。
Cytotherapy. 2011 Aug;13(7):835-47. doi: 10.3109/14653249.2011.571245. Epub 2011 Apr 21.
7
RORC and Foxp3 axis in cerebrospinal fluid of patients with neuro-Behçet's disease.神经白塞病患者脑脊液中的 RORC 和 Foxp3 轴。
J Neuroimmunol. 2011 Apr;233(1-2):249-53. doi: 10.1016/j.jneuroim.2011.01.012. Epub 2011 Mar 1.
8
Induction of regulatory T cells by infliximab in Behcet's disease.英夫利昔单抗诱导白塞病调节性 T 细胞。
Invest Ophthalmol Vis Sci. 2011 Jan 21;52(1):476-84. doi: 10.1167/iovs.10-5916.
9
CD4+ FoxP3+ regulatory T cells confer infectious tolerance in a TGF-beta-dependent manner.CD4+ FoxP3+ 调节性T细胞以转化生长因子-β依赖的方式赋予感染性耐受。
J Exp Med. 2008 Sep 1;205(9):1975-81. doi: 10.1084/jem.20080308. Epub 2008 Aug 18.
10
Decreased percentages of regulatory T cells in peripheral blood of patients with Behcet's disease before ocular attack: a possible predictive marker of ocular attack.白塞病患者眼部发作前外周血中调节性T细胞百分比降低:眼部发作的一种可能预测标志物。
Mod Rheumatol. 2008;18(4):354-8. doi: 10.1007/s10165-008-0064-x. Epub 2008 Apr 22.